Fig. 2From: In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic feverThe vaccine construction, modeling, and refinement. A TLR4 Adjuvant-vaccine (V1), B V1 model, C V1 model refined and crude superimposition, D TLR3-8 Adjuvant-vaccine (V2), E V2 vaccine structure, and F V2 refined and initial model superimpositionBack to article page